HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sheehan, M. T. Search for Related Content PubMed PubMed Citation Articles by Sheehan, M. T.

Polycystic Ovarian Syndrome: Diagnosis and Management

Department of Endocrinology, Marshfield Clinic-Wausau Center, Wausau, Wisconsin

REPRINT REQUESTS: Michael T. Sheehan, MD, Department of Endocrinology, Marshfield Clinic-Wausau Center, 2727 Plaza Drive, Wausau, WI 54401, Telephone: 715-847-3550, Fax: 715-847-3039, Email: sheehan.michael{at}marshfieldclinic.org

Polycystic ovarian syndrome (PCOS) affects 4% to 12% of women of reproductive age. The lack of well-defined diagnostic criteria makes identification of this common disease confusing to many clinicians. Also, with the varied manifestations of the disorder a patient may present to any one of several providers: an internist, family practitioner, nurse practitioner, pediatrician, gynecologist, dermatologist, or endocrinologist. Furthermore, the most distressing aspect of PCOS for any given patient may change over time, from hirsutism as a teenager to infertility as a young adult–potentially requiring several different providers along the way. It is important, therefore, that those caring for these patients understand not only the management issues pertinent to their specialty, but also appreciate the other potential health risks in these women. Recent insights into the pathophysiology of PCOS have shown insulin resistance to play a substantial role and as such have brought the long-term issues of type 2 diabetes mellitus and its resultant increased risk of coronary artery disease to the forefront. No longer can irregular menses and/or hirsutism be thought of as benign nuisances.

This review will focus on the two most confusing aspects of PCOS for the practicing provider–diagnosis/differential diagnosis and treatment options. Special attention is given to the role of insulin resistance and the potential utility of insulin sensitizers in management. The benefit and utmost importance of lifestyle modification for the long-term health of these women is stressed as well. It is hoped that some clarity in this regard will allow more women to not only be diagnosed and managed properly for their presenting symptoms (hirsutism, irregular menses, etc.), but also to be educated and managed for the continuing health risk of insulin resistance throughout their lives.

Key Words: Polycystic ovarian syndrome • Hirsutism • Infertility • Irregular menses • Obesity • Insulin resistance • Insulin sensitizers • Women’s health

This article has been cited by other articles:

				R. A. Sayer, A. Deutsch, and M. S. Hoffman Clitoroplasty Obstet. Gynecol., August 1, 2007; 110(2): 523 - 525. [Abstract] [Full Text] [PDF]